Search research articles
Contact Us
Filters
Showing results (41-50 of 134) with videos related to
Page
of 14
Sort By:
British Journal of Cancer
|
September 29, 2022
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
H Lalchungnunga, Wen Hao, John M Maris, et al.
Plos One
|
December 20, 2012
Time-lapse imaging of neuroblastoma cells to determine cell fate upon gene knockdown
Richa Batra, Nathalie Harder, Sina Gogolin, et al.
Molecular Cancer Therapeutics
|
April 5, 2011
Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist nutlin-3
Tom Van Maerken, Ali Rihani, Daniel Dreidax, et al.
Cell Systems
|
August 28, 2017
Cell-Cycle Position of Single MYC-Driven Cancer Cells Dictates Their Susceptibility to a Chemotherapeutic Drug
Tatsiana Ryl, Erika E Kuchen, Emma Bell, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 5, 2024
Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy
Yaron Vinik, Avi Maimon, Vinay Dubey, et al.
Cancers
|
March 6, 2020
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Martin Michaelis, Yvonne Voges, Florian Rothweiler, et al.
Cancer Research
|
March 10, 2011
CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells
Kai-Oliver Henrich, Tobias Bauer, Johannes Schulte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2006
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients
Kai-Oliver Henrich, Matthias Fischer, Daniel Mertens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Heterogeneity of the MYCN oncogene in neuroblastoma
Jessica Theissen, Marc Boensch, Ruediger Spitz, et al.
Cancer Letters
|
November 29, 2012
MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells
Sina Gogolin, Richa Batra, Nathalie Harder, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 134) with videos related to
Sort By:
Page
of 14
British Journal of Cancer
|
September 29, 2022
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
H Lalchungnunga, Wen Hao, John M Maris, et al.
Plos One
|
December 20, 2012
Time-lapse imaging of neuroblastoma cells to determine cell fate upon gene knockdown
Richa Batra, Nathalie Harder, Sina Gogolin, et al.
Molecular Cancer Therapeutics
|
April 5, 2011
Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist nutlin-3
Tom Van Maerken, Ali Rihani, Daniel Dreidax, et al.
Cell Systems
|
August 28, 2017
Cell-Cycle Position of Single MYC-Driven Cancer Cells Dictates Their Susceptibility to a Chemotherapeutic Drug
Tatsiana Ryl, Erika E Kuchen, Emma Bell, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 5, 2024
Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy
Yaron Vinik, Avi Maimon, Vinay Dubey, et al.
Cancers
|
March 6, 2020
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Martin Michaelis, Yvonne Voges, Florian Rothweiler, et al.
Cancer Research
|
March 10, 2011
CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells
Kai-Oliver Henrich, Tobias Bauer, Johannes Schulte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2006
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients
Kai-Oliver Henrich, Matthias Fischer, Daniel Mertens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Heterogeneity of the MYCN oncogene in neuroblastoma
Jessica Theissen, Marc Boensch, Ruediger Spitz, et al.
Cancer Letters
|
November 29, 2012
MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells
Sina Gogolin, Richa Batra, Nathalie Harder, et al.
Page
of 14